Product image

Formiget Capsules

Formiget Capsules – Comprehensive Asthma and COPD Maintenance

Formiget is an advanced respiratory therapy combining Budesonide and Formoterol for the regular treatment of chronic airway diseases. In patients with asthma, it is indicated for those 12 years and older who require both an inhaled corticosteroid and a long-acting beta-agonist. It is particularly effective for individuals whose symptoms remain uncontrolled on steroid therapy alone or for those already stable on this specific combination.

For adults with Chronic Obstructive Pulmonary Disease (COPD), Formiget provides symptomatic treatment for patients with a history of frequent exacerbations and significant airflow obstruction. The medication is delivered via a Dry Powder Inhaler (DPI) capsule, ensuring the active ingredients reach deep into the bronchial passages. Budesonide reduces airway inflammation while Formoterol provides rapid and long-lasting bronchodilation. Regular maintenance use improves lung function and significantly enhances daily quality of life.

  • Indicated for the regular treatment of asthma (12+ years).
  • Maintenance therapy for airflow obstruction in COPD patients.
  • Combines anti-inflammatory and bronchodilator actions.
  • Available as: DPI Capsules 200/6mcg and 400/12mcg.

You may also like

Take it to your cart

Ezole Capsules
Ezole Capsules

Ezole Capsules – Targeted Suppression of Stomach Acid

Ezole Capsules contain Esomeprazole, a potent proton pump inhibitor de...

Risek Capsules
Risek Capsules

Risek Capsules – Comprehensive Acid-Related Disease Management

Risek is a established gastrointestinal treatment used for a...

EN-URA Tablets
EN-URA Tablets

EN-URA Tablets – Targeted Relief for Overactive Bladder

EN-URA is a specialized therapeutic option designed to manage bother...

Saltra Inhaler
Saltra Inhaler

Saltra Inhaler – Comprehensive Respiratory Maintenance Therapy

Saltra Inhaler is a specialized respiratory medication used f...

Image NewsLetter
Icon primary
Newsletter

Subscribe our newsletter

By clicking the button, you are agreeing with our Term & Conditions

Your experience on this site will be improved by allowing cookies Cookie Policy